AI Science Tracker
EN

Laboratory of Complex Biological Systems and Bioinformatics (CBB), Department of Bioinformatics, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, Iran

1 discovery from 2020

Discoveries

Unraveling the molecular heterogeneity in type 2 diabetes: a potential subtype discovery followed by metabolic modeling

Source check: Source checked. Not independent scientific confirmation.

Finding: Primary BMC Medical Genomics Results identify three T2DM expression clusters and distinct metabolic flux/gene patterns from 154 skeletal-muscle profiles; the earlier Research Square V1 reports the same three clusters and pathway result. These are computationally inferred subtypes, not clinically validated categories.

Technology: GA-SVM selects expression features; hierarchical clustering groups T2DM profiles and flux models characterize pathways.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
GA-SVM selects expression features; hierarchical clustering groups T2DM profiles and flux models characterize pathways.
Test and result
From 63 newly diagnosed T2DM and 91 controls, 26 genes classify groups at 94% repeated CV; three patient clusters show distinct expression/flux patterns.
Limitation / still unknown
Repeated internal CV for classification; metabolic mechanism inference is computational and no independent clinical cohort or experimental perturbation validates subtype biology.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1186/s12920-020-00767-0 · https://pubmed.ncbi.nlm.nih.gov/32831068/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.